StrokeNCT03295032
A Mixed-methods Evaluation of an Adapted Acceptance and Commitment Therapy (ACT) Group for Stroke Survivors
A study testing Acceptance and Commitment Therapy (ACT) in people with Stroke and Acceptance and Commitment Therapy, run by Cardiff University at 4 sites in United Kingdom.
Trial summary
Stroke is one of the main causes of acquired adult disability in the UK. Many psychological problems can also occur post-stroke; this has a marked impact on health service usage. As such, there is an outstanding need to increase and improve psychological resources within stroke services. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Stroke, Acceptance and Commitment Therapy
- What is being tested?
- Acceptance and Commitment Therapy (ACT)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 53 participants
- Where
- 4 sitesUnited Kingdom
- Study dates
- 1 Mar 2016to 29 Dec 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- All participants must be >18 years
- Clinical diagnosis of stroke (or carers of someone who has experienced a stroke)
- Must be able to understand English and communicate responses.
- The target volunteer has been referred to this stroke-adapted ACT course by a clinician.
Who cannot join
- Patients with any other acquired brain injury e.g. traumatic brain injury, encephalitis, tumours etc.
- Patients diagnosed with a degenerative condition e.g. dementias.
- Significant cognitive/language impairment that would prevent them from engaging with the group.
- Those experiencing severe psychotic symptoms
- Those who are receiving other therapies, as part of a multicomponent intervention which would prevent any changes specific to group psychotherapy to be estimated (with the exception of drugs for anxiety and depression).
Trial locations and contacts
4 sites in 1 country.
United Kingdom4 sites
Bristol Area Stroke Foundation
Bristol, England, BS13 9JN
Cardiff & Vale NHS Trust
Cardiff, Wales, CF62 2XX
Cwm Taf NHS Trust
Merthyr Tydfil, Wales, CF40 2LU
Aneurin Bevan NHS Trust
Newport, Wales, NP20 4SZ
About this study
Official title: A Mixed-methods Evaluation of an Adapted Acceptance and Commitment Therapy (ACT) Group for Stroke Survivors and Their Carers: ACTivate Your Life After Stroke
Stroke is one of the main causes of acquired adult disability in the UK. Many psychological problems can also occur post-stroke; this has a marked impact on health service usage. As such, there is an outstanding need to increase and improve psychological resources within stroke services.
The investigators proposed to adapt and evaluate the effectiveness of an acceptance and commitment therapy (ACT) group intervention for adult stroke survivors and their carers. The group will endeavour to promote positive adjustment and reduce levels of depression and anxiety.
This study will have two parts.
Read the detailed description
Stroke is one of the main causes of acquired adult disability in the UK. In England and Wales, over 900,000 people are living with the chronic illness, which can cause sufferers to be highly dependent on others for their care. Many psychological problems can also occur including: depression, anxiety and fatigue. This has a marked impact on health service usage. There is an outstanding need to increase and improve psychological resources within these services.
Acceptance and Commitment Therapy (ACT) has a well-established evidence base for reducing psychological distress in individuals with mental illness and physical health conditions including: diabetes, chronic pain, epilepsy \& cancer. It is hoped that the investigators can apply this same model to support stroke survivors and their carers.
The investigators propose to evaluate the effectiveness of an adapted ACT group intervention for adult stroke survivors and their carers. The benefit of ACT is that it is transdiagnostic therefore applicable to the very wide range of psychological problems found in carers and survivors after stroke. This ACT group is a stroke adapted version of the already existing 'ACTivate your life' course, which is being run by the NHS for people with mental health difficulties across South Wales. The course endeavours to promote positive adjustment and reduce levels of depression and anxiety, using the core tenets of ACT.
This study will have two parts. Part 1: a quantitative phase evaluating the effectiveness of the ACT group using outcome data in comparison to a waiting list control across three time points. Part 2: A qualitative phase exploring stroke survivors experiences of the ACT group and their perceptions of any change from group attendance.
PART 1:
Design: The study will employ a longitudinal randomised design using a questionnaire methodology. The study will not be blind. Outcome measures will be taken pre, post and at a two month follow up.
Participants and Recruitment: Participants will be recruited across five NHS University Health Boards/Trusts: Cardiff and Vale University Health Board, Aneurin Bevan university health board, Cwm Taf University Health Board, North Bristol NHS Trust and University Hospitals Bristol NHS Foundation Trust. Bristol Area Stroke Foundation charity (BASF) will also assist in the recruitment across Bristol and will host the course for all Bristol participants. The individuals may be recruited at any stage of the care pathway after discharge from hospital.
Potential participants will be identified by clinicians working within the stroke teams. All interested participants will be provided with a course flyer, written participant information sheet and consent form. Once consent has been obtained, participants will be randomly allocated into the treatment group or placed on a waiting list (control group). Carer/stroke survivor pairs will be allocated together. Participants who were allocated into the waiting list group initially, will be offered to attend the ACT group once the first group has finished and 2 month follow-up data has been collected.
The intervention group will attend a four week, 2.5 hour (maximum) psycho-educational group that focuses on assisting stroke survivors and carers to learn a set of simple, and teachable, techniques that focuses on changing patterns of experience and thinking. The learning will involve understanding the principles of ACT via PowerPoint presentations which have been adapted to include stroke specific examples and have been simplified to allow for potential cognitive impairment.
Sample Size: In order for sufficient power (0.80) and using standard parameters of alpha = 0.05, a total sample size of between 40 - 64 participants are required in total.
Control Group: After the intervention group is finished, the waiting list group will be offered the intervention which will consist of the exact same process as above.
Data Protection: Data will be anonymised with randomly allocated codes. Identifiable personal data will be stored separately in a locked unit.
Analysis: A mixed model (within and between participants) MANOVA will be looking for group x time interaction between the experimental and control.
PART 2:
Design: Semi-structured interviews will be conducted to explore stroke survivors' subjective experiences of the ACT group. These will be conducted >1 month after the group and will be framed around 8 main questions. Interviews will be undertaken in consultation rooms or in the participants' own home, lasting no more than 1 hour. The number of interviews conducted will depend upon the length of time it takes to reach data saturation (i.e. when no new information is emerging from the dataset), which is recommended for the type of qualitative analysis being performed. Interviews will be audio-recorded to support the researcher with transcription and data analysis. Participants will be made aware of this in advance on the consent form.
Sample Size: The investigators envisage data saturation will be achieved anywhere between 12 - 25 participant interviews.
Sampling: Sampling will begin purposefully in the first instance to offer maximum variation in stroke survivors reported experiences of the group i.e. a diverse range of participants who expressed interest to partake will be interviewed. Theoretical sampling will then be used for subsequent interviews, whereby participants are selected based on the emerging theory.
Recruitment: Similar to above, participants will be recruited from the University Health Boards (UHBs) and BASF charity, at any stage of the care pathway following discharge. Participants for this phase of the study will consist only of stroke survivors.
Data Protection: All data will be stored on a password protected and encrypted USB device for the duration of the study, and will subsequently be destroyed after use. Participants will be assigned a numerical identifier during transcription to protect their identity.
Analysis: Grounded Theory (GT) will be used in phase 2, for both data collection and analysis which will occur simultaneously. GT aims to identify emerging themes from the data and develop new, contextualised theories (i.e. "grounded" in the data). As such, data collected after each interview will be transcribed and reviewed in an evolving process. Interview questions will be revised to progressively focus on the emerging theory. This process is in line with the inductive nature of the GT approach.
- Conditions
- Stroke, Acceptance and Commitment Therapy
- Being tested
- Acceptance and Commitment Therapy (ACT)
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Acceptance and Commitment Therapy (ACT)Behavioural
ACT is a psychological intervention; in this study it is being delivered as a 4-week psycho-educational group to stroke survivors and carers.
Rather than attempting to control or ameliorate pain and suffering, ACT advocates that individuals remain open to internal private experiences (both positive and negative) and should focus on committing to a life which is congruent with their core values. Individuals learn to modify their relationship with these experiences, rather than change the experiences per se through processes such as mindfulness, acceptance and attention to values. This fundamental premise of ACT helps cultivate psychological flexibility.
| Study group | Role | What they receive |
|---|---|---|
| group-based ACT | Experimental | Stroke survivors were randomised into group-based ACT intervention consisting of 2hr sessions for four consecutive weeks. Receives: Behavioral: Acceptance and Commitment Therapy (ACT) |
| Waiting list control | No intervention | Waiting list control - received treatment as usual. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Measuring a change in PHQ9 scores
measure of depression
Measured: baseline, 4 weeks and two month follow-up
Secondary outcomes (4)
Measuring a change in GAD7 scores
measure of anxiety
Measured: baseline, 4 weeks and two month follow-up
Measuring a change in Warwick and Edinburgh Mental Wellbeing Scale (WEMWBS) scores
measure of mental wellbeing
Measured: baseline, 4 weeks and two month follow-up
Measuring a change in Adult Hope Scale (AHS) scores
measure of hopefulness
Measured: baseline, 4 weeks and two month follow-up
Measuring a change in EQ-5D-5L scores
measure of quality of life
Measured: baseline, 4 weeks and two month follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Sep 2017
- Study start1 Mar 2016
- Primary completion29 Dec 2016
- Study completion29 Dec 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for StrokeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Part 1: Randomised Controlled Trial with an intervention (ACT group) and Waiting List Control arm. Part 2: Interviews
- Masking
- None (open label)
- Enrolment
- 53 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cardiff University
- Sponsor type
- University, hospital or other
- Collaborators
- Cwm Taf University Health Board (NHS), Cardiff and Vale University Health Board, Aneurin Bevan University Health Board, North Bristol NHS Trust, University Hospitals Bristol and Weston NHS Foundation Trust, BASF
- Responsible party
- Principal investigator, Rebecca Large, Cardiff University
- Investigators
- Professor Reg Morris, PhD, Study director, Cardiff University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03295032
- Sponsor's protocol ID
- Cardiff University
- Status last verified
- Sep 2017
- First submitted
- 15 Sep 2017
- Last updated
- 27 Sep 2017
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Campbell Burton CA, Murray J, Holmes J, Astin F, Greenwood D, Knapp P. Frequency of anxiety after stroke: a systematic review and meta-analysis of observational studies. Int J Stroke. 2013 Oct;8(7):545-59. doi: 10.1111/j.1747-4949.2012.00906.x. Epub 2012 Sep 27.
PubMed 23013268Constructing Grounded Theory: A practical guide through qualitative analysis Kathy Charmaz Constructing Grounded Theory: A practical guide through qualitative analysis Sage 224 pound19.99 0761973532 0761973532 [Formula: see text]. Nurse Res. 2006 Jul 1;13(4):84. doi: 10.7748/nr.13.4.84.s4.
PubMed 27702218Feros DL, Lane L, Ciarrochi J, Blackledge JT. Acceptance and Commitment Therapy (ACT) for improving the lives of cancer patients: a preliminary study. Psychooncology. 2013 Feb;22(2):459-64. doi: 10.1002/pon.2083. Epub 2011 Oct 6.
PubMed 23382134Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther. 2006 Jan;44(1):1-25. doi: 10.1016/j.brat.2005.06.006.
PubMed 16300724Kangas M, McDonald S. Is it time to act? The potential of acceptance and commitment therapy for psychological problems following acquired brain injury. Neuropsychol Rehabil. 2011 Apr;21(2):250-76. doi: 10.1080/09602011.2010.540920. Epub 2011 Jan 17.
PubMed 21246445
Study at a glance
From the registry record, last updated by the sponsor on 27 Sep 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Mixed-methods Evaluation of an Adapted Acceptance and Commitment Therapy (ACT) Group for Stroke Survivors and Their Carers: ACTivate Your Life After Stroke
- ClinicalTrials.gov ID
- NCT03295032
- Acronym / sponsor ID
- Cardiff University
- Conditions
- Stroke, Acceptance and Commitment Therapy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 53 participants (actual)
- Lead sponsor
- Cardiff UniversityUniversity, hospital or other
- Collaborators
- Cwm Taf University Health Board (NHS), Cardiff and Vale University Health Board, Aneurin Bevan University Health Board, North Bristol NHS Trust, University Hospitals Bristol and Weston NHS Foundation Trust, BASF
- Study start
- 1 Mar 2016 (actual)
- Primary completion
- 29 Dec 2016 (actual)
- Study completion
- 29 Dec 2016 (actual)
- First posted
- 27 Sep 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Stroke is one of the main causes of acquired adult disability in the UK. Many psychological problems can also occur post-stroke; this has a marked impact on health service usage. As such, there is an outstanding need to increase and improve psychological resources within stroke services.
The investigators proposed to adapt and evaluate the effectiveness of an acceptance and commitment therapy (ACT) group intervention for adult stroke survivors and their carers. The group will endeavour to promote positive adjustment and reduce levels of depression and anxiety.
This study will have two parts.
Detailed description
Stroke is one of the main causes of acquired adult disability in the UK. In England and Wales, over 900,000 people are living with the chronic illness, which can cause sufferers to be highly dependent on others for their care. Many psychological problems can also occur including: depression, anxiety and fatigue. This has a marked impact on health service usage. There is an outstanding need to increase and improve psychological resources within these services.
Acceptance and Commitment Therapy (ACT) has a well-established evidence base for reducing psychological distress in individuals with mental illness and physical health conditions including: diabetes, chronic pain, epilepsy \& cancer. It is hoped that the investigators can apply this same model to support stroke survivors and their carers.
The investigators propose to evaluate the effectiveness of an adapted ACT group intervention for adult stroke survivors and their carers. The benefit of ACT is that it is transdiagnostic therefore applicable to the very wide range of psychological problems found in carers and survivors after stroke. This ACT group is a stroke adapted version of the already existing 'ACTivate your life' course, which is being run by the NHS for people with mental health difficulties across South Wales. The course endeavours to promote positive adjustment and reduce levels of depression and anxiety, using the core tenets of ACT.
This study will have two parts. Part 1: a quantitative phase evaluating the effectiveness of the ACT group using outcome data in comparison to a waiting list control across three time points. Part 2: A qualitative phase exploring stroke survivors experiences of the ACT group and their perceptions of any change from group attendance.
PART 1:
Design: The study will employ a longitudinal randomised design using a questionnaire methodology. The study will not be blind. Outcome measures will be taken pre, post and at a two month follow up.
Participants and Recruitment: Participants will be recruited across five NHS University Health Boards/Trusts: Cardiff and Vale University Health Board, Aneurin Bevan university health board, Cwm Taf University Health Board, North Bristol NHS Trust and University Hospitals Bristol NHS Foundation Trust. Bristol Area Stroke Foundation charity (BASF) will also assist in the recruitment across Bristol and will host the course for all Bristol participants. The individuals may be recruited at any stage of the care pathway after discharge from hospital.
Potential participants will be identified by clinicians working within the stroke teams. All interested participants will be provided with a course flyer, written participant information sheet and consent form. Once consent has been obtained, participants will be randomly allocated into the treatment group or placed on a waiting list (control group). Carer/stroke survivor pairs will be allocated together. Participants who were allocated into the waiting list group initially, will be offered to attend the ACT group once the first group has finished and 2 month follow-up data has been collected.
The intervention group will attend a four week, 2.5 hour (maximum) psycho-educational group that focuses on assisting stroke survivors and carers to learn a set of simple, and teachable, techniques that focuses on changing patterns of experience and thinking. The learning will involve understanding the principles of ACT via PowerPoint presentations which have been adapted to include stroke specific examples and have been simplified to allow for potential cognitive impairment.
Sample Size: In order for sufficient power (0.80) and using standard parameters of alpha = 0.05, a total sample size of between 40 - 64 participants are required in total.
Control Group: After the intervention group is finished, the waiting list group will be offered the intervention which will consist of the exact same process as above.
Data Protection: Data will be anonymised with randomly allocated codes. Identifiable personal data will be stored separately in a locked unit.
Analysis: A mixed model (within and between participants) MANOVA will be looking for group x time interaction between the experimental and control.
PART 2:
Design: Semi-structured interviews will be conducted to explore stroke survivors' subjective experiences of the ACT group. These will be conducted >1 month after the group and will be framed around 8 main questions. Interviews will be undertaken in consultation rooms or in the participants' own home, lasting no more than 1 hour. The number of interviews conducted will depend upon the length of time it takes to reach data saturation (i.e. when no new information is emerging from the dataset), which is recommended for the type of qualitative analysis being performed. Interviews will be audio-recorded to support the researcher with transcription and data analysis. Participants will be made aware of this in advance on the consent form.
Sample Size: The investigators envisage data saturation will be achieved anywhere between 12 - 25 participant interviews.
Sampling: Sampling will begin purposefully in the first instance to offer maximum variation in stroke survivors reported experiences of the group i.e. a diverse range of participants who expressed interest to partake will be interviewed. Theoretical sampling will then be used for subsequent interviews, whereby participants are selected based on the emerging theory.
Recruitment: Similar to above, participants will be recruited from the University Health Boards (UHBs) and BASF charity, at any stage of the care pathway following discharge. Participants for this phase of the study will consist only of stroke survivors.
Data Protection: All data will be stored on a password protected and encrypted USB device for the duration of the study, and will subsequently be destroyed after use. Participants will be assigned a numerical identifier during transcription to protect their identity.
Analysis: Grounded Theory (GT) will be used in phase 2, for both data collection and analysis which will occur simultaneously. GT aims to identify emerging themes from the data and develop new, contextualised theories (i.e. "grounded" in the data). As such, data collected after each interview will be transcribed and reviewed in an evolving process. Interview questions will be revised to progressively focus on the emerging theory. This process is in line with the inductive nature of the GT approach.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Part 1: Randomised Controlled Trial with an intervention (ACT group) and Waiting List Control arm. Part 2: Interviews
| Arm | Type | Receives |
|---|---|---|
| group-based ACT | Experimental | Behavioral: Acceptance and Commitment Therapy (ACT)Stroke survivors were randomised into group-based ACT intervention consisting of 2hr sessions for four consecutive weeks. |
| Waiting list control | No intervention | –Waiting list control - received treatment as usual. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- All participants must be >18 years
- Clinical diagnosis of stroke (or carers of someone who has experienced a stroke)
- Must be able to understand English and communicate responses.
- The target volunteer has been referred to this stroke-adapted ACT course by a clinician.
Key exclusion criteria (5 listed)
- Patients with any other acquired brain injury e.g. traumatic brain injury, encephalitis, tumours etc.
- Patients diagnosed with a degenerative condition e.g. dementias.
- Significant cognitive/language impairment that would prevent them from engaging with the group.
- Those experiencing severe psychotic symptoms
- Those who are receiving other therapies, as part of a multicomponent intervention which would prevent any changes specific to group psychotherapy to be estimated (with the exception of drugs for anxiety and depression).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Acceptance and Commitment Therapy (ACT)ACT is a psychological intervention; in this study it is being delivered as a 4-week psycho-educational group to stroke survivors and carers. Rather than attempting to control or ameliorate pain and suffering, ACT advocates that individuals remain open to internal private experiences (both positive and negative) and should focus on committing to a life which is congruent with their core values. Individuals learn to modify their relationship with these experiences, rather than change the experiences per se through processes such as mindfulness, acceptance and attention to values. This fundamental premise of ACT helps cultivate psychological flexibility. | Behavioural | group-based ACT |
Primary outcome
Measuring a change in PHQ9 scores
Time frame: baseline, 4 weeks and two month follow-up
measure of depression
4 secondary outcomes
Measuring a change in GAD7 scores
Time frame: baseline, 4 weeks and two month follow-up
Measuring a change in Warwick and Edinburgh Mental Wellbeing Scale (WEMWBS) scores
Time frame: baseline, 4 weeks and two month follow-up
Measuring a change in Adult Hope Scale (AHS) scores
Time frame: baseline, 4 weeks and two month follow-up
Measuring a change in EQ-5D-5L scores
Time frame: baseline, 4 weeks and two month follow-up
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Sep 2017.
- Background: PubMed 23013268Campbell Burton CA, Murray J, Holmes J, Astin F, Greenwood D, Knapp P. Frequency of anxiety after stroke: a systematic review and meta-analysis of observational studies. Int J Stroke. 2013 Oct;8(7):545-59. doi: 10.1111/j.1747-4949.2012.00906.x. Epub 2012 Sep 27.
- Background: PubMed 27702218Constructing Grounded Theory: A practical guide through qualitative analysis Kathy Charmaz Constructing Grounded Theory: A practical guide through qualitative analysis Sage 224 pound19.99 0761973532 0761973532 [Formula: see text]. Nurse Res. 2006 Jul 1;13(4):84. doi: 10.7748/nr.13.4.84.s4.
- Background: PubMed 23382134Feros DL, Lane L, Ciarrochi J, Blackledge JT. Acceptance and Commitment Therapy (ACT) for improving the lives of cancer patients: a preliminary study. Psychooncology. 2013 Feb;22(2):459-64. doi: 10.1002/pon.2083. Epub 2011 Oct 6.
- Background: PubMed 16300724Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther. 2006 Jan;44(1):1-25. doi: 10.1016/j.brat.2005.06.006.
- Background: PubMed 21246445Kangas M, McDonald S. Is it time to act? The potential of acceptance and commitment therapy for psychological problems following acquired brain injury. Neuropsychol Rehabil. 2011 Apr;21(2):250-76. doi: 10.1080/09602011.2010.540920. Epub 2011 Jan 17.
- Individual participant dataSharing planned: No
Related trials for Stroke
Recruiting
Connectomic Alterations Following Acute Ischemic Stroke in the MCA Territory
Ischemic Stroke
RecruitingObservational study
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Intracerebral Hemorrhage, Stroke
Active, not recruitingPhase 4
A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment
Ischemic Stroke Hospitalized, Impairment, Cognitive
Not yet recruitingPhase 4
Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke
Ischemic Stroke
RecruitingObservational study
CoMind Early Feasibility Study
Intracranial Pressure, Intracranial Pressure Changes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Professor Reg Morris, PhD study director
Cardiff University
4 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Acceptance and Commitment Therapy (ACT) in people with Stroke and Acceptance and Commitment Therapy, run by Cardiff University at 4 sites in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Sep 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Measuring a change in PHQ9 scores (time frame: baseline, 4 weeks and two month follow-up). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03295032, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Sep 2017.